Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study

Clinical trial NCT07026604 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07026604
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cavernous Malformation, Cerebral

Start date: 2025-07-01
Primary completion: 2026-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.